Immunocore Holdings plc (NASDAQ:IMCR) Poised To Extend Recent Momentum After Positive Q2 Business Update
Immunocore enters the near term with mixed technicals but clear fundamental strength from recent commercial and pipeline milestones. Liquidity and a high gross margin underpin a valuation that WMDST currently classifies as under-valued.









